A longevity summit, in our own backyard
From 1 to 4 October, Hong Kong hosted the 2nd Asia-Pacific Healthy Longevity International Summit, organised by the Asia-Pacific Longevity Medicine Society and the Kitalys Institute at the Hopewell Hotel in Wanchai. Organisers expected more than 2,000 global leaders across longevity medicine, geroscience, pharma, digital health, AI and regulatory science, with 1,000+ confirmed attendees on the day. This was not a wellness expo. It brought together clinicians, researchers, investors and policymakers under the theme "From Vision to Action in Healthy Longevity," focused on turning lab science into care people can actually access.
Why Asia, and why now
The organisers made a bold claim at the summit: that "the centre of gravity in biomedical research and development, policy, funding and innovation is moving from West to East." Behind the claim is a simple demographic fact. By 2030, roughly one in four people in Asia will be over 60, and countries including Japan, South Korea, Taiwan and Singapore have already reached "super-aged" status. Hong Kong's Asia-Pacific Longevity Medicine Society, which co-organised the summit, is registered here, positioning the city as what organisers called a "strategic hub" for the region's longevity economy, rather than a side venue for a Western-led field.
What was actually on the agenda
The pre-summit days (1–2 October) covered the fundamentals of longevity medicine, clinically proven technologies, and how to actually run a longevity clinic: operations, client experience and measurable outcomes. One session tackled consensus standards for clinics and how AI is being used in longevity medicine. The main summit (3–4 October) moved into cross-sector territory: academia, healthcare providers, industry and policymakers working on shared standards, investment pathways and care models, with sessions on stem cells, muscle health, nutrition and mindfulness alongside the clinical science.
A theme that ran through multiple sessions: longevity clinics are being positioned as the "front line of clinical translation," the place where lab research actually reaches people, alongside lifestyle medicine and AI-driven tools for earlier, more personalised care.
The breakthrough awards: a hint at where the science is headed
The pre-summit also hosted the Top 10 Longevity Breakthrough Awards 2026, judged on scientific and medical evidence. One of the ten awardees, the Japanese biotech company I Peace, won for iPSF, a cell-free product derived from the culture supernatant of induced pluripotent stem (iPS) cells. iPS cell technology lets ordinary adult cells be reprogrammed back into a stem-cell-like state, with potential uses in regenerative medicine. iPSF itself is still in research and development and is not an approved treatment for any disease.
The detail matters less than the direction: the awards are increasingly going to cell-level and regenerative science, not just supplements or lifestyle apps, which signals where serious investment in this field is heading over the next few years.
What this actually means for you
Most of what was discussed at this summit, stem cell therapies, AI-driven diagnostics, won't be sitting on a pharmacy shelf anytime soon, and most of it will be expensive and clinic-based when it does arrive. That is worth knowing before anyone sells you a longevity product based on "what was announced in Hong Kong this month."
But the summit's own agenda is a useful reality check: muscle health, nutrition and mindfulness sat on the same programme as stem cells and AI, not as an afterthought. Experts at this kind of event consistently point back to the same evidence-backed basics: regular exercise, a protein- and fibre-rich diet, consistent sleep, stress management and early health screening. These remain the most affordable and accessible longevity tools available, while the clinic-based science catches up and becomes more accessible over time.
The bottom line
Hong Kong just positioned itself at the centre of one of the fastest-growing fields in medicine, and the people building that field spent four days agreeing that lifestyle fundamentals and cutting-edge science belong on the same stage. The cell therapies and AI tools will take years to reach most people. The basics they discussed alongside, protein, movement, sleep, stress and fibre, are available to you today.
Sources
- APAC-LMS and Kitalys to host Healthy Longevity in Hong Kong — Lifespan.io, on summit theme, pre-summit/main summit structure, and Hong Kong's role
- Asia-Pacific steps up in longevity medicine — Longevity.Technology, on session topics (stem cells, muscle health, nutrition, mindfulness, AI) and the Longevity Clinics World directory
- The 2026 Asia-Pacific Healthy Longevity International Summit — Longevity Live, on dates, attendance, and the Top 10 Breakthrough Awards
- I Peace selected as a Top 10 awardee — PR Newswire APAC, on the iPSF award and I Peace's iPS cell technology
- Asia's longevity boom arrives in an older, richer region — Fortune, on the demographic shift behind the trend (1 in 4 Asians over 60 by 2030)